BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34684574)

  • 21. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L; Qiu S; Genest J
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
    Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
    J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S-alk(en)yl cysteines of garlic inhibit cholesterol synthesis by deactivating HMG-CoA reductase in cultured rat hepatocytes.
    Liu L; Yeh YY
    J Nutr; 2002 Jun; 132(6):1129-34. PubMed ID: 12042421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robinetinidol-flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Niu H; Chao Y; Li K; Li J; Gong W; Huang W
    Mol Med Rep; 2015 Jan; 11(1):561-6. PubMed ID: 25339541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei.
    Coppens I; Bastin P; Levade T; Courtoy PJ
    Mol Biochem Parasitol; 1995 Jan; 69(1):29-40. PubMed ID: 7723786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice.
    Sun JH; Liu X; Cong LX; Li H; Zhang CY; Chen JG; Wang CM
    Lipids Health Dis; 2017 Aug; 16(1):145. PubMed ID: 28764799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of mevalonate on 3-hydroxy-3-methylglutaryl-CoA reductase activity and the absolute rate of cholesterol biosynthesis in human monocyte-derived macrophages.
    Patel DD; Knight BL
    Eur J Biochem; 1985 Nov; 153(1):117-23. PubMed ID: 4065145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of bovine lipoproteins in the regulation of steroidogenesis and HMG-CoA reductase in bovine adrenocortical cells.
    Rainey WE; Rodgers RJ; Mason JI
    Steroids; 1992 Apr; 57(4):167-73. PubMed ID: 1325689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased sensitivity to dietary cholesterol in diabetic and hypothyroid rats associated with low levels of hepatic HMG-CoA reductase expression.
    Ness GC; Gertz KR
    Exp Biol Med (Maywood); 2004 May; 229(5):407-11. PubMed ID: 15096652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of removal of lipoproteins of different composition on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and hepatic very low density lipoprotein secretion.
    Van Zuiden PE; Erickson SK; Cooper AD
    J Lipid Res; 1983 Apr; 24(4):418-28. PubMed ID: 6854151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMG-CoA reductase inhibition: anti-inflammatory effects beyond lipid lowering?
    März W; Wieland H
    Herz; 2000 Mar; 25(2):117-25. PubMed ID: 10829251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GCG-rich tea catechins are effective in lowering cholesterol and triglyceride concentrations in hyperlipidemic rats.
    Lee SM; Kim CW; Kim JK; Shin HJ; Baik JH
    Lipids; 2008 May; 43(5):419-29. PubMed ID: 18365267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids.
    Bok SH; Lee SH; Park YB; Bae KH; Son KH; Jeong TS; Choi MS
    J Nutr; 1999 Jun; 129(6):1182-5. PubMed ID: 10356084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
    Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2.
    Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ
    Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
    Beg ZH; Reznikov DC; Avigan J
    Arch Biochem Biophys; 1986 Jan; 244(1):310-22. PubMed ID: 3004340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential downregulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice.
    Johnston TP; Baker JC; Jamal AS; Hall D; Emeson EE; Palmer WK
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):831-42. PubMed ID: 10598127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.